Partners
Our Partners
LIONEX is actively participating and/or coordinating a number of research projects funded by the European Union, The WHO, FIND, German Federal Ministry for Research and Education (BMBF), German Federal Ministry of Commerce (BMWi). Research fields include diagnostics, vaccine and drug development, bladder cancer biomarkers and bladder cancer therapeutics. LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.
LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.
LIONEX cooperates with large research institutions, big pharma and large, international diagnostic companies from countries across the globe.
Only a limited list of partners is mentioned here.
Mozambique:
Italy:
Azienda Ospedaliero Universitaria
Policlinico Paolo Giaccone Palermo
Tor Vergana
UNIVERSITA DEGLI STUDI DI FIRENZE
Universita degli Studi di Roma
Central Laboratory of Advanced Diagnosis and Biomedical Research(CLADIBIOR),
University of Palermo
Spain:
CIN2-CSIC Barcelona
CSIC
IGTP
Universidade De Vigo
Sweden:
Stockholms Universitat
Karolinska Institutet
Mexico:
Czech Republic:
IMIC
UK:
Kings College, London
Sporegen Ltd..
St George’s, University of London
Department for Environment Food & Rural Affairs
South Africa:
Stellenbosh Univesity, S. Africa
Slovenia:
If you have any question please contact us
Lionex
© 2018 Lionex GmbH
Last update:
Lionex GmbHLIONEX GmbH